Berne-based LEM Surgical, an innovative company specializing in surgical robotics, has successfully completed its financing round B at the end of December 2023. CHF 22 million in funding have been secured from new investors from both the United States and Switzerland.
The newly acquired funds will be used to propel the advancement of LEM Surgical’s product development initiatives and readiness for FDA submission in the second half of 2024.
Kellerhals Carrard has supported LEM Surgical in the transaction. The team was co-lead by associate Robin Juchler (pictured left) and partner Beat Brechbühl (pictured right) and also includes Michèle Remund and Quentin Bärtschi.